Sign in Subscribe
United States. Securities and Exchange Commission

ARCA biopharma, Inc. Submits FORM 8-K with SEC on July 9, 2021

Strategic Insights

— 1 min read

ARCA biopharma, Inc. submitted a FORM 8-K report to the Securities and Exchange Commission (SEC) on July 9, 2021. The report details the company's actions at its 2021 Annual Meeting of Stockholders, which took place on July 8, 2021. The meeting saw the election of Dr. Raymond Woosley and Mr. Dan Mitchell to the board of directors, the ratification of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2021, and the approval of executive compensation.

Key Takeaways:

  • The company held its 2021 Annual Meeting of Stockholders on July 8, 2021, where stockholders voted on the election of directors, the ratification of the independent registered public accounting firm, and the approval of executive compensation.
  • Dr. Raymond Woosley and Mr. Dan Mitchell were elected to the board of directors, each receiving over 1.55 million votes in favor.
  • Stockholders also ratified the selection of KPMG LLP as the company's independent registered public accounting firm, with 6.01 million votes in favor.
  • The resolution concerning executive compensation was approved on an advisory basis, with 1.39 million votes in favor.
  • The company's stockholders voted on August 8, 2021, on the three proposals, with Dr. Woosley and Mr. Mitchell receiving the highest number of favorable votes.
  • The company's executive compensation plan was approved by stockholders, with 1.39 million votes in favor.
  • The tabulation of votes cast with respect to each matter voted upon reveals a high level of participation, with over 4 million votes cast on the non-binding advisory vote on executive compensation.

Statistics:

  • 1,562,242 votes for Mr. Dan Mitchell
  • 1,555,220 votes for Dr. Raymond Woosley
  • 6,010,419 votes in favor of ratifying the selection of KPMG LLP
  • 252,973 votes against selecting KPMG LLP
  • 108,445 abstentions on the executive compensation vote
  • 4,064,222 broker non-votes

Sources:

  • ARCA biopharma, Inc. (2021-07-09). FORM 8-K, Current Report. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

Read more